DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,977 Cr | ₹12,559 Cr | ₹11,812 Cr | ₹10,558 Cr | ₹7,779 Cr |
What is the latest Appropriations of DIVIS LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹13,977 Cr |
| Mar2024 | ₹12,559 Cr |
| Mar2023 | ₹11,812 Cr |
| Mar2022 | ₹10,558 Cr |
| Mar2021 | ₹7,779 Cr |
How is Appropriations of DIVIS LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,977 Cr | 11.29 | |
| Mar2024 | ₹12,559 Cr | 6.32 | |
| Mar2023 | ₹11,812 Cr | 11.88 | |
| Mar2022 | ₹10,558 Cr | 35.73 | |
| Mar2021 | ₹7,779 Cr | - | |
Compare Appropriations of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹163,050.2 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
| MANKIND PHARMA | ₹87,425.9 Cr | -4.9% | 0.4% | -18.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -5.4% |
-2.4% |
3.9% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses